supp.fit

Chondroitin: study protocols

60 study groups say how much Chondroitin participants took a day. These are the doses the studies gave. They are not a recommendation.

Chondroitin: what the research found →

Dose per serving from products

41 products in our catalogue print how much Chondroitin a serving holds.

Most common: 1 g to 2.5 g, 39% of 41 products.

Dose per servingProducts
50 mg or less
1
50 mg to 100 mg
4
100 mg to 250 mg
5
250 mg to 500 mg
8
500 mg to 1 g
7
1 g to 2.5 g
16

Dose per serving from research

60 study groups in 49 studies say how much Chondroitin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g and 1 g to 2.5 g, 42% of 60 study groups each.

Daily doseStudy groups
100 mg or less
2
100 mg to 250 mg
5
250 mg to 500 mg
3
500 mg to 1 g
25
1 g to 2.5 g
25

Commonly used together

28 of 60 study groups took Chondroitin with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Glucosamine
24
Hyaluronic Acid
5
Type-II Collagen
4

60 study groups

Study
Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study
2021 · chondroitin sulfate only · Adults aged 45–75 with symptomatic knee osteoarthritis
800 mg2 years—
Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA
1998 · CS 4&6 group · Patients with osteoarthritis of the finger joints
400 mg3 years—
Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study
2021 · glucosamine sulfate and chondroitin sulfate (double active) · Adults aged 45–75 with symptomatic knee osteoarthritis
800 mg2 years—
Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial
2009 · chondroitin 4 and 6 sulfate group · Patients with knee osteoarthritis
800 mg2 years309
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)
2017 · Group CS · Adults older than 50 with symptomatic primary knee osteoarthritis
800 mg26 weeks199
Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee
2010 · chondroitin sulfate · Patients with femorotibial knee osteoarthritis; age and sex not specified
1.2 g26 weeks178
Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial
2005 · CS · Patients with knee osteoarthritis
800 mg2 years150
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center
2011 · CS group · Patients with symptomatic hand osteoarthritis and radiographic evidence of hand OA
800 mg26 weeks80
Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study
2001 · CS group · Patients with femorotibial osteoarthritis of the knee; age and sex not reported
1 g90 days63
Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo
1998 · CS 3 x 400 mg/day capsules · Patients with mono- or bilateral knee osteoarthritis, Kellgren and Lawrence radiographic grade I to III
1.2 g90 days43
Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo
1998 · CS 1200 mg/day oral gel · Patients with mono- or bilateral knee osteoarthritis, Kellgren and Lawrence radiographic grade I to III
1.2 g90 days40
Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
2019 · experimental group (non-animal CS) · Men and women aged 55 years and over with overweight (BMI 25–30 kg/m²) and moderate knee osteoarthritis or related mobility impairment and joint discomfort
600 mg12 weeks30
Bifidobacterium animalis subsp. lactis Probio-M8 enhances chondroitin efficacy for knee osteoarthritis in postmenopausal women via the gut-joint axis
2025 · placebo group · Postmenopausal women aged 50–70 with clinically diagnosed knee osteoarthritis
900 mg90 days30
Effects of chondroitin sulfate on brain response to painful stimulation in knee osteoarthritis patients. A randomized, double-blind, placebo-controlled functional magnetic resonance imaging study
2017 · CS group · Patients with knee osteoarthritis; age and sex not stated
800 mg120 days22
Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo
2004 · chondroitin sulfate (CS) group · patients with symptomatic knee osteoarthritis
800 mg180 days—
Potential effects of chondroitin sulfate on joint swelling: a GAIT report
2008 · chondroitin sulfate · Adults with symptomatic, radiographic knee osteoarthritis
1.2 g24 weeks—
Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study
2010 · CS · Patients with symptomatic knee osteoarthritis and concomitant psoriasis
800 mg90 days—
Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study
2013 · CS 1200 · Men and women over 45 years with knee osteoarthritis
1.2 g90 days—
Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study
2013 · CS 3*400 · Men and women over 45 years with knee osteoarthritis
1.2 g90 days—
Efficacy of Chondroitin Sulfate for Painful Knee Osteoarthritis: A One-Year, Randomized, Double-Blind, Multicenter Clinical Study in Japan
2018 · low-dose group (control group) · Patients with painful, Kellgren-Lawrence grade 2–3 knee osteoarthritis
260 mg1 year—
Efficacy of Chondroitin Sulfate for Painful Knee Osteoarthritis: A One-Year, Randomized, Double-Blind, Multicenter Clinical Study in Japan
2018 · high-dose group · Patients with painful, Kellgren-Lawrence grade 2–3 knee osteoarthritis
1.56 g1 year—
Cost-Effectiveness Analysis of Pharmaceutical-Grade Chondroitin Sulfate for Knee Osteoarthritis Based on Individual Patient Data from a Randomized Clinical Trial
2025 · chondroitin sulfate group · Adults over 50 years old with primary knee osteoarthritis and knee pain for at least 3 months
800 mg26 weeks—
Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis
1996 · CS group · Patients with knee osteoarthritis
1.2 g90 days—
Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis
1998 · chondroitin sulfate group · Patients with idiopathic or clinically symptomatic knee osteoarthritis, Kellgren and Lawrence radiological scores I–III; age and sex not reported
800 mg26 weeks—
Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study
1998 · chondroitin sulfate group · Adults aged 35–78 years, both sexes, with symptomatic knee osteoarthritis
800 mg1 year—
[Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6)]
1998 · CS 4&6 · Patients with femorotibial osteoarthritis of the knee
800 mg1 year—
Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
2015 · GIII · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified
1.2 g16 weeks306
Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
2015 · GI · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified
1.2 g16 weeks302
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study
2016 · GC group · Men and women aged 40–75 with moderate-to-severe knee osteoarthritis
1.2 g180 days66
Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial
2018 · GC Group · Males and females aged 40–75 years with mild to moderate knee osteoarthritis
600 mg180 days61
Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial
2016 · Glu/Cho group · Japanese adults aged 52–87 with knee pain and/or stiffness
180 mg24 weeks50
Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
2017 · GCM · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified
1.2 g90 days50
Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
2017 · GC · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified
1.2 g90 days49
Bifidobacterium animalis subsp. lactis Probio-M8 enhances chondroitin efficacy for knee osteoarthritis in postmenopausal women via the gut-joint axis
2025 · probiotic group · Postmenopausal women aged 50–70 with clinically diagnosed knee osteoarthritis
900 mg90 days38
[A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis]
2019 · Group 2 · Patients with bladder pain syndrome/interstitial cystitis; sex and age range not specified
1.17 g12 weeks29
Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
2009 · Glucosamine HCl plus chondroitin sulfate group (G+C) · Adults with moderate to severe osteoarthritis of the knee; age and sex distribution not specified for this arm.
600 mg90 days26
The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial
2021 · A+HA group · Men and women aged 40 years or older with knee osteoarthritis and mild knee pain
250 mg8 weeks24
A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study
2001 · active medication group · People diagnosed with capsulitis, disk displacement, disk dislocation, or painful osteoarthritis of the temporomandibular joint
1.2 g12 weeks14
Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis
2000 · intervention group · Adults with knee osteoarthritis; age and sex not reported
1.6 g26 weeks—
Potential effects of chondroitin sulfate on joint swelling: a GAIT report
2008 · glucosamine plus chondroitin sulfate · Adults with symptomatic, radiographic knee osteoarthritis
1.2 g24 weeks—
Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study
2012 · GCQ supplement · Japanese subjects with symptomatic knee osteoarthritis
60 mg16 weeks—
Novel Hydrolyzed Chicken Sternal Cartilage Extract Improves Facial Epidermis and Connective Tissue in Healthy Adult Females: A Randomized, Double-Blind, Placebo-Controlled Trial
2019 · intervention · Females aged 39–59 years described as healthy adults
200 mg12 weeks—
Curcumagalactomannoside/Glucosamine Combination Improved Joint Health Among Osteoarthritic Subjects as Compared to Chondroitin Sulfate/Glucosamine: Double-Blinded, Randomized Controlled Study
2020 · Group II (CHN-GLN) · Adults with confirmed class I–III osteoarthritis; ages not reported; 38 males and 42 females across both groups
830 mg12 weeks—
Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial
2021 · GS/CS group · Patients with knee osteoarthritis, Kellgren-Lawrence grades 2 or 3, with a mean WOMAC pain subscale score of at least 40 mm
1.2 g24 weeks—
Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study
2015 · GCQID group · Japanese women and men aged 40–74 years with knee pain
60 mg16 weeks50
Effects of cartilage-supporting nutritional supplementation on knee osteoarthritis symptoms and quality of life in a 12-week randomized double-blind placebo-controlled pilot study
2025 · Verum · Adults with mild-to-moderate knee osteoarthritis and slight-to-moderate knee pain; mean age 62.7 years; women and men
200 mg12 weeks36
Effect of an oral preparation containing hyaluronic acid, chondroitin sulfate, hydrolyzed collagen type II and hydrolyzed keratin on synovial fluid features and clinical indices in knee osteoarthritis. A pilot study
2020 · treatment group · Adults with knee osteoarthritis and a swollen joint
240 mg4 weeks15
Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
1999 · combination therapy · male U.S. Navy diving and special warfare personnel with chronic pain and radiographic degenerative joint disease of the knee or low back
1.2 g16 weeks—
Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male Volunteers
2019 · Nonanimal chondroitin sulfate · Healthy male volunteers
2.4 g1 day—
Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male Volunteers
2019 · Animal-derived chondroitin sulfate · Healthy male volunteers
2.4 g1 day—
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
2015 · chondroitin sulfate · Adults aged 45–75 with chronic knee pain and medial tibio-femoral compartment narrowing consistent with symptomatic knee osteoarthritis
800 mg2 years151
Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study
2016 · Chondroitin sulfate · Men and women aged 40 years or older with primary symptomatic knee osteoarthritis and clinical synovitis
400 mg543 days97
Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study
2017 · chondroitin sulfate · Adults with symptomatic knee osteoarthritis and clinical synovitis; age and sex range not specified
1.2 g2 years97
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
2011 · CS group · Adults aged 40–80 years, both sexes, with primary knee osteoarthritis and clinical signs of synovitis
800 mg1 year35
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
2011 · Placebo group followed by CS · Adults aged 40–80 years, both sexes, with primary knee osteoarthritis and clinical signs of synovitis
800 mg26 weeks34
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
2015 · glucosamine-chondroitin combination · Adults aged 45–75 with chronic knee pain and medial tibio-femoral compartment narrowing consistent with symptomatic knee osteoarthritis
800 mg2 years151
Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients
2020 · Combined glucosamine hydrochloride plus chondroitin sulfate (GH+CS) · Patients with knee osteoarthritis; age and sex not specified
1.2 g26 weeks96
Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans
2015 · Glucosamine and chondroitin (G&C) intervention · Healthy, overweight, non-smoking men and women aged 20–55 years
1.2 g4 weeks18
Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint
2015 · study group · Women aged 18–40 with internal derangement of the temporomandibular joint, pain lasting longer than 4 weeks, and limitation in mouth opening
1.2 g8 weeks—
Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial
2021 · GLN-CHN combination group · Adults with knee osteoarthritis
830 mg6 weeks—